DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Distigmine

Distigmine

  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

  • Enhancement of Acetylcholinesterase Inhibitory Activity for the Soft Coral Associated Fungus Aspergillus Unguis SPMD-EGY by Media Composition

    Enhancement of Acetylcholinesterase Inhibitory Activity for the Soft Coral Associated Fungus Aspergillus Unguis SPMD-EGY by Media Composition

  • The Effects of Donepezil, an Acetylcholinesterase Inhibitor, on Impaired Learning and Memory in Rodents

    The Effects of Donepezil, an Acetylcholinesterase Inhibitor, on Impaired Learning and Memory in Rodents

  • Download PDF (131K)

    Download PDF (131K)

  • (12) Patent Application Publication (10) Pub. No.: US 2006/0058336A1 Nakanishi Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0058336A1 Nakanishi Et Al

  • Biol. Pharm. Bull. 42(7): 1064-1068 (2019)

    Biol. Pharm. Bull. 42(7): 1064-1068 (2019)

  • 12.2% 122,000 135M Top 1% 154 4,800

    12.2% 122,000 135M Top 1% 154 4,800

  • Pharmaceuticals and Medical Devices Safety Information No

    Pharmaceuticals and Medical Devices Safety Information No

  • Acetylcholinesterase Inhibitors of Natural Origin

    Acetylcholinesterase Inhibitors of Natural Origin

  • Antimyasthenics

    Antimyasthenics

  • Guidelines for Biological Treatment of Schizophrenia, Part 2

    Guidelines for Biological Treatment of Schizophrenia, Part 2

  • Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL

    Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL

  • PH 1.14 Parasympathomimetics Cholinergic Drugs Cholinergic and Adrenergic System

    PH 1.14 Parasympathomimetics Cholinergic Drugs Cholinergic and Adrenergic System

  • Treatment Standards and Individualized Therapy of Myasthenia Gravis

    Treatment Standards and Individualized Therapy of Myasthenia Gravis

  • Alkaloids – Secrets of Life

    Alkaloids – Secrets of Life

  • Symptoms and Pharmacological Treatment of Parkinson’S Disease

    Symptoms and Pharmacological Treatment of Parkinson’S Disease

  • Methylnaltrexone Bromide

    Methylnaltrexone Bromide

  • Toxicology Reference Laboratory

    Toxicology Reference Laboratory

Top View
  • Pharmacology for Dentistry
  • Spectrophotometric Determination of Distigmine Bromide, Cyclopentolate
  • 455 Demonstration of Muscarinic and Nicotinic
  • Rare Case of Iatrogenic Myocardial Infarction Induced by Use of Pyridostigmine
  • Decision Trees to Characterise the Roles of Permeability and Solubility on the Prediction of Oral Absorption
  • Pharmacokinetics of Neostigmine and Pyridostigmine in Man
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Asp8302 Non-Confidential Summary
  • L'huperzine A: Un Nouvel Inhibiteur Des Cholinestérases Pour La
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • 777 Assessment of the Usefulness and Optimal
  • Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human
  • Masterpass : Pharmacology in 7 Days for Medical Students
  • Myasthenia Gravis
  • Medicines and Related Substances Act No. 101 of 1965
  • Anatomical Classification Guidelines V2016
  • Biol. Pharm. Bull. 40(7): 1092-1100 (2017)
  • Drug Dictionary for Dentistry.Pdf


© 2024 Docslib.org    Feedback